1. Home
  2. VCSA vs ADGM Comparison

VCSA vs ADGM Comparison

Compare VCSA & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCSA
  • ADGM
  • Stock Information
  • Founded
  • VCSA 2009
  • ADGM 2011
  • Country
  • VCSA United States
  • ADGM United States
  • Employees
  • VCSA N/A
  • ADGM N/A
  • Industry
  • VCSA Computer Software: Prepackaged Software
  • ADGM
  • Sector
  • VCSA Technology
  • ADGM
  • Exchange
  • VCSA Nasdaq
  • ADGM NYSE
  • Market Cap
  • VCSA 38.6M
  • ADGM 33.4M
  • IPO Year
  • VCSA N/A
  • ADGM N/A
  • Fundamental
  • Price
  • VCSA $3.34
  • ADGM $1.65
  • Analyst Decision
  • VCSA Buy
  • ADGM
  • Analyst Count
  • VCSA 4
  • ADGM 0
  • Target Price
  • VCSA $6.08
  • ADGM N/A
  • AVG Volume (30 Days)
  • VCSA 79.6K
  • ADGM 52.9K
  • Earning Date
  • VCSA 11-07-2024
  • ADGM 02-15-2025
  • Dividend Yield
  • VCSA N/A
  • ADGM N/A
  • EPS Growth
  • VCSA N/A
  • ADGM N/A
  • EPS
  • VCSA N/A
  • ADGM N/A
  • Revenue
  • VCSA $949,936,000.00
  • ADGM $543,000.00
  • Revenue This Year
  • VCSA N/A
  • ADGM N/A
  • Revenue Next Year
  • VCSA N/A
  • ADGM N/A
  • P/E Ratio
  • VCSA N/A
  • ADGM N/A
  • Revenue Growth
  • VCSA N/A
  • ADGM 187.30
  • 52 Week Low
  • VCSA $2.07
  • ADGM $1.36
  • 52 Week High
  • VCSA $11.70
  • ADGM $9.34
  • Technical
  • Relative Strength Index (RSI)
  • VCSA 43.35
  • ADGM N/A
  • Support Level
  • VCSA $3.75
  • ADGM N/A
  • Resistance Level
  • VCSA $4.79
  • ADGM N/A
  • Average True Range (ATR)
  • VCSA 0.41
  • ADGM 0.00
  • MACD
  • VCSA -0.13
  • ADGM 0.00
  • Stochastic Oscillator
  • VCSA 0.00
  • ADGM 0.00

About VCSA Vacasa Inc.

Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.

About ADGM ADAGIO MEDICAL HOLDINGS INC

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Share on Social Networks: